193 related articles for article (PubMed ID: 20216419)
21. Current treatment of age-related macular degeneration.
Zarbin M; Szirth B
Optom Vis Sci; 2007 Jul; 84(7):559-72. PubMed ID: 17632299
[TBL] [Abstract][Full Text] [Related]
22. Investigational drugs inhibiting complement for the treatment of geographic atrophy.
Ferro Desideri L; Artemiev D; Bernardi E; Paschon K; Zandi S; Zinkernagel M; Anguita R
Expert Opin Investig Drugs; 2023; 32(11):1009-1016. PubMed ID: 37902056
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents.
Tomany SC; Wang JJ; Van Leeuwen R; Klein R; Mitchell P; Vingerling JR; Klein BE; Smith W; De Jong PT
Ophthalmology; 2004 Jul; 111(7):1280-7. PubMed ID: 15234127
[TBL] [Abstract][Full Text] [Related]
24. Anti-VEGF agents for age-related macular degeneration.
Ozkiris A
Expert Opin Ther Pat; 2010 Jan; 20(1):103-18. PubMed ID: 20021287
[TBL] [Abstract][Full Text] [Related]
25. [Pathogenesis of age-related macular degeneration].
Kaarniranta K; Seitsonen S; Paimela T; Meri S; Immonen I
Duodecim; 2009; 125(2):145-53. PubMed ID: 19341030
[TBL] [Abstract][Full Text] [Related]
26. The burden of age-related macular degeneration: a value-based analysis.
Brown MM; Brown GC; Sharma S; Stein JD; Roth Z; Campanella J; Beauchamp GR
Curr Opin Ophthalmol; 2006 Jun; 17(3):257-66. PubMed ID: 16794438
[TBL] [Abstract][Full Text] [Related]
27. Status of therapies in development for the treatment of age-related macular degeneration.
Hunt DW; Margaron P
IDrugs; 2003 May; 6(5):464-9. PubMed ID: 12789601
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for choroidal neovascularization and geographic atrophy in the complications of age-related macular degeneration prevention trial.
Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group
Ophthalmology; 2008 Sep; 115(9):1474-9, 1479.e1-6. PubMed ID: 18502512
[TBL] [Abstract][Full Text] [Related]
29. Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration.
Yaspan BL; Williams DF; Holz FG; Regillo CD; Li Z; Dressen A; van Lookeren Campagne M; Le KN; Graham RR; Beres T; Bhangale TR; Honigberg LA; Smith A; Henry EC; Ho C; Strauss EC;
Sci Transl Med; 2017 Jun; 9(395):. PubMed ID: 28637922
[TBL] [Abstract][Full Text] [Related]
30. Age-related macular degeneration.
Brucker AJ
Retina; 2009 Jun; 29(6 Suppl):S2-4. PubMed ID: 19553791
[TBL] [Abstract][Full Text] [Related]
31. Measuring geographic atrophy in advanced age-related macular degeneration.
Sunness JS; Bressler NM; Tian Y; Alexander J; Applegate CA
Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1761-9. PubMed ID: 10393046
[TBL] [Abstract][Full Text] [Related]
32. Age-related macular degeneration: from neovascular to atrophic.
Roy M; Kuehl E
Ann Ophthalmol; 1989 Nov; 21(11):429-31. PubMed ID: 2482684
[TBL] [Abstract][Full Text] [Related]
33. Investigational Agents in Development for the Treatment of Geographic Atrophy Secondary to Age-Related Macular Degeneration.
Yu HJ; Wykoff CC
BioDrugs; 2021 May; 35(3):303-323. PubMed ID: 33893984
[TBL] [Abstract][Full Text] [Related]
34. Subfoveal exudative age-related macular degeneration: evidence for preoccult disease.
Shah AR; Del Priore LV
Curr Opin Ophthalmol; 2009 May; 20(3):182-7. PubMed ID: 19367162
[TBL] [Abstract][Full Text] [Related]
35. LAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls.
Richer S; Devenport J; Lang JC
Optometry; 2007 May; 78(5):213-9. PubMed ID: 17478338
[TBL] [Abstract][Full Text] [Related]
36. Influence of experimental chronic high-pressure glaucoma on age-related macular degeneration in rhesus monkeys.
Jonas JB; Hayreh SS
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):2972-7. PubMed ID: 10967053
[TBL] [Abstract][Full Text] [Related]
37. Pathogenesis of lesions in late age-related macular disease.
Holz FG; Pauleikhoff D; Klein R; Bird AC
Am J Ophthalmol; 2004 Mar; 137(3):504-10. PubMed ID: 15013875
[TBL] [Abstract][Full Text] [Related]
38. Macular degeneration: recent advances and therapeutic opportunities.
Rattner A; Nathans J
Nat Rev Neurosci; 2006 Nov; 7(11):860-72. PubMed ID: 17033682
[TBL] [Abstract][Full Text] [Related]
39. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study.
Klein R; Klein BE; Tomany SC; Cruickshanks KJ
Ophthalmology; 2003 Jun; 110(6):1273-80. PubMed ID: 12799274
[TBL] [Abstract][Full Text] [Related]
40. Pegcetacoplan treatment for geographic atrophy due to age-related macular degeneration: a plain language summary of the FILLY study.
Liao DS; Metlapally R; Joshi P
Immunotherapy; 2022 Sep; 14(13):995-1006. PubMed ID: 35860926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
